Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic

  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

114.23 +1.81 (+1.61%)
Official Closing Price Updated: 7:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
40 41 Next >
Two Blue Chip Health Companies The Institutions Are Buying
Johnson & Johnson and Abbott Laboratories are two Dividend Kings the analysts are buying, one stock is ready to rebound and the other to lead the market. 
Via MarketBeat
11 Analysts Have This to Say About Abbott Laboratories
Via Benzinga
2 Ultra-Reliable Dividend Stocks You Can Buy Now and Hold Forever
Here are two stocks that investors can count on to deliver increasing dividend payments for many years to come. 
Via The Motley Fool
Have $1,000? 2 Top Dividend Stocks to Buy Right Now
Dividend stocks can help investors grow their portfolios in all types of markets. 
Via The Motley Fool
2 Supercharged Dividend Stocks to Buy in a Bear Market
Don't let these income stocks pass you by. 
Via The Motley Fool
2 Dividend Aristocrats to Buy for 2023
You can count on these dividend stocks to continue raising their payouts for years to come. 
Via The Motley Fool
Is This Stock-Split Stock a Buy For 2023?
Don't buy this company's shares for its recent stock split. 
Via The Motley Fool
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Via Benzinga
2 Reasons to Buy Abbott Labs and 1 Reason to Sell
The healthcare company offers growth and value. 
Via The Motley Fool
Got $500? Where to Invest It Before 2023
These top stocks look like a deal right now. 
Via The Motley Fool
Is AbbVie Stock a Buy Now?
The pharmaceutical company prepared well as Humira approaches its patent cliff next year. 
Via The Motley Fool
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
Via Benzinga
3 Top Dividend Kings to Buy for the Long Haul
Dividend stocks are an easy option to boost income. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
2 Stocks Down 75% and 26% to Buy Right Now
It's time to go bargain hunting. 
Via The Motley Fool
FDA Outlines Strategy To Review Infant Formula Production Rules
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
8 Dividend Aristocrats to Buy Now for a Lifetime of Passive Income
Dividend stocks are a great way to protect against a downturn and these are the cream of the crop. 
Via The Motley Fool
Better Dividend Stock: AbbVie or Viatris?
These pharmaceutical companies are profitable and offer above-average dividends. 
Via The Motley Fool
2 Unbeatable Dividend Stocks Billionaires Keep Buying in a Bear Market
Some of the world's most successful investors made big bets on these dividend payers recently. 
Via The Motley Fool
Could an Investment in AbbVie Give You $10,000 in Annual Dividend Income by Retirement?
This is a stock that rewards long-term investors through continual dividend increases. 
Via The Motley Fool
Want $10,000 in Annual Dividend Income by Retirement? Here's How Much You Should Invest in AbbVie Today.
This is a stock that rewards long-term investors through continual dividend increases. 
Via The Motley Fool
AbbVie Boosts Its Dividend: Is the Dividend King a Buy?
Shares of the pharmaceutical stock have left the S&P 500 index in the dust so far this year. 
Via The Motley Fool
2 Reasons to Buy AbbVie Stock and 1 Reason to Sell
The pharmaceutical company's golden goose is about to stop laying golden eggs, but that won't be a permanent problem. 
Via The Motley Fool
Want Passive Income in 2023? Buy These Dividend Kings
These stocks offer you a gift: recurrent income just for owning them. 
Via The Motley Fool
7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond
With so many troubles ailing the economy and the broader market, investors should focus on these no-brainer blue-chip stocks to buy. 
Via InvestorPlace
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.79% on an annualized basis producing an average annual return of 12.9%. Currently, Abbott Laboratories has a... 
Via Benzinga
Better Buy: Johnson & Johnson vs. Abbott Laboratories
These two healthcare giants are among the safest stocks investors can buy right now. 
Via The Motley Fool
3 Top Healthcare Stocks Defying the Bear Market
These healthcare companies haven't been slowed by macroeconomic conditions. 
Via The Motley Fool
3 Food Processing Dividend Stocks That Could Benefit From Food Shortages Driven By Russia-Ukraine War
With global supply chain shortages impacting nearly every sector of the economy in the past two years, will global food shortages worsen? As the U.S. 
Via Benzinga
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
40 41 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.